Morgan Stanley Reiterates Equal-Weight Rating on Centene Corporation (CNC)

Market Context

Centene Corporation operates in the Healthcare sector. The stock currently trades at $67.05 with a market capitalization of $19.9B. The stock has gained 50.1% over the past 52 weeks.

Analyst coverage from Morgan Stanley provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Centene Corporation.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Centene Corporation

Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 28, 2026	Barclays	Overweight	N/A
Oct 28, 2026	Morgan Stanley	Equal-Weight	N/A
Oct 28, 2026	Baird	Neutral	N/A
Oct 28, 2026	Cantor Fitzgerald	Overweight	N/A
Oct 28, 2026	B of A Securities	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View CNC Stock Page